Prefilled Syringes Market

Prefilled Syringes Market (Type: Safety Syringes and Conventional Syringes; and Design: Single Chamber, Dual Chamber, and Multiple Chamber) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Prefilled Syringes Market Outlook 2031

  • The global prefilled syringes market was valued at US$ 13.6 Bn in 2021
  • The global market is projected to advance at a CAGR of 10.1% from 2022 to 2031
  • The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031

Analysts’ Viewpoint on Prefilled Syringes Market Scenario

The market for prefilled syringes is growing due to the expansion of home care services, increase in usage of injectable medications, surge in prevalence of chronic diseases, and advantages of prefilled syringes over conventional vials. Furthermore, technology developments related to prefilled syringes are boosting the market. However, availability of alternate medicine delivery techniques, stringent government regulations, and product recalls are anticipated to restrain the global market. On the other hand, development of biologics and biosimilars; and rise in demand for injectable medications in prefilled forms present lucrative opportunities for companies operating in the global prefilled syringes market.

prefilled syringes market

Global Prefilled Syringes Market Introduction

Prefilled syringe is a disposable syringe that already contains the substance to be injected. Prefilled syringe has emerged as one of the most convenient drug delivery methods in the last few years. It is one of the rapidly growing options for unit dose delivery. Plastic disposable syringes have ushered in a revolution in the healthcare industry. Introduction of sterile, prefilled syringes that allow safe self-administration of injectable drugs without the need for hospitalization is driving the prefilled syringes market.

Chronic diseases, such as type 1 diabetes, are becoming more common in large populations around the world. Patients with type 1 diabetes receive insulin intravenously on a regular basis to control their blood sugar levels. Prefilled syringes can make self-administration more convenient and viable due to their ease of usage. According to the International Diabetes Federation, approximately 537 million adults (20-79 years) had diabetes in December 2021, and approximately 6.7 million deaths occurred globally due to diabetes in 2021.

The COVID-19 pandemic has had a positive impact on the global prefilled syringes market. In September 2021, BD, a U.S.-based multinational medical technology company, demonstrated the suitability of its glass prefilled syringes for use with mRNA COVID-19 vaccine shots that require ultralow temperature storage. According to the company, switching from vials to prefilled syringes can reduce the complexity and cost of vaccine administration.

Request a sample to get extensive insights into the Prefilled Syringes Market

Preference for Self-administrable Devices Bolstering Demand for Prefilled Syringes

Rise in incidence and prevalence of chronic and lifestyle diseases worldwide is a major driver of the prefilled syringes market. Furthermore, demand for self-injection devices, such as saline syringes, is increasing owing to the convenience and safety associated with their usage. Diabetes affected 436 million individuals worldwide in 2019 (prevalence 9.3%). By 2045, the number is projected to climb to 700 million (prevalence 10.9%). Additionally, more than 1.1 million children and teenagers have type 1 diabetes (Source: International Diabetes Federation).

Insulin-dependent diabetics are increasingly turning to dependable and risk-free methods of self-injection such as prefilled insulin syringes. For instance, NovoLog FlexPen prefilled syringe is a fast acting insulin that is used to improve blood sugar control in adults and children with diabetes mellitus. Integration of autoinjectors and pen injectors with prefilled syringes is one of the major factors influencing the need for self-administrable devices.. Thus, preference for self-administration is anticipated to boost the prefilled syringes market size in the next few years.

Reduction of Overfill Waste and Mitigation of Risk of Misuse Augmenting Prefilled Syringes Market

Introduction of needlestick safety-equipped devices, advanced lubrication technology, and the type of multi-chamber syringes are all major technological developments in the syringe industry. Widespread usage of prefilled syringes has enabled pharmaceutical companies to reduce drug waste, while also increasing product lifespan. Prefilled syringes are regarded as the best method for storing medications, as they promote self-administration, reduce overfill waste, and mitigate the risk of misuse. This benefits patients, healthcare practitioners, and manufacturers in equal measure.

Request a custom report on Prefilled Syringes Market

Increase in Cases of Needlestick Injuries Propelling Demand for Safety Syringes

In terms of type, the safety syringes segment is projected to dominate the global market with 77% share by 2031. Safety syringes have removable or permanently connected needles as well as an internal safety device. Several countries have passed laws mandating the usage of safety syringes. Safety syringes are being used in order to reduce needlestick injuries. Several hospitals, diagnostic centers, and general practitioners employ safety prefilled syringes for drug delivery, as these offer less overfills and better safety to patients.

Technological Advancements in Single Chamber Prefilled Syringes

Prefilled syringes are available in various designs. These include single chamber prefilled syringes, dual chamber prefilled syringes, and multiple chamber prefilled syringes. Based on design, the single chamber segment dominated the global market with around 70% share in 2021. Single-chamber prefilled syringes are used for injecting prefilled vaccine products and biological or pharmaceutical products. They are available at various sales channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Major companies offering single-chamber prefilled syringes are focusing on developing technological solutions for the single-chamber prefilled syringe market. For instance, in 2019, Biocorp, a medical device manufacturing company based in France, released Injay, a single-chamber prefilled syringe that uses a Near Field Communication (NFC) chip to store information such as drug name, batch number, and expiration date, and transfers this data when scanned with the provided code. This information is transmitted to the doctor from the patient's phone at the specified date and time when the patient injected the drug. Such developments are expected to propel the segment in the next few years.

Demand for dual chamber prefilled syringes is also increasing at a steady pace across the globe. This is estimated to augment the dual chamber prefilled syringes market during the forecast period.

Rise in Adoption of Highly Compatible and Heat Resistant Glass Prefilled Syringes

In terms of material, the glass segment led the global prefilled syringes market with around 60% share in 2021. Demand for glass-based prefilled syringes is expected to rise in the next few years, owing to significant advantages of these syringes. Glass prefilled syringes offer high stability, prevention of drug interaction with oxygen or water vapor, and high compatibility. Furthermore, glass prefilled syringes are more heat resistant.

Growth in Number of Hospital Pharmacies to Boost Global Prefilled Syringes Market

In terms of distribution channel, the hospital pharmacies segment is projected to dominate the global market with 50% share by 2031. Hospitals are key consumers of prefilled syringes. Hospital pharmacies have remained the most popular and convenient location for vaccinations and cancer treatments. Increase in number of diseases and surge in geriatric population across the globe are anticipated to drive the hospital pharmacies segment in the near future.

Regional Outlook of Global Prefilled Syringes Market

North America dominated the global prefilled syringes market in 2021. The market in the region is anticipated to grow at a CAGR of 6.8% from 2022 to 2031 due to the increase in research and development activities in research labs and pharmaceutical companies; and government initiatives for various vaccination programs. Furthermore, the prefilled syringes market in North America is expected to be driven by the increase in adoption of safety prefilled syringes and emphasis on needlestick injury prevention.

The market in Asia Pacific is growing at a rapid pace owing to the increase in rate of diabetes, infectious diseases, and cancer. This is driving the demand for specific treatments, which in turn is augmenting the demand for prefilled syringes. Furthermore, technological advancements and product launches in Asia Pacific, particularly in Japan (Daikyo-Crystal Zenith) and China; and improved reimbursement policies are propelling the prefilled syringes market in Asia Pacific. The Government of China’s health care reforms, favorable regulatory environment, increase in pharmaceutical development, aging population, healthcare innovations, and presence of the highest number of diabetic patients in the country are also propelling the market in the region.

Analysis of Key Players in Global Prefilled Syringes Market

The global prefilled syringes market report concludes with the company profiles section, which includes information about key players in the global prefilled syringes market. Leading players analyzed in the report are B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company (BD), Catalent, Inc., Elcam Medical, Gerresheimer AG, Nipro Corporation, SCHOTT AG, Terumo Corporation, Vetter Pharma, Weigao Group, and West Pharmaceutical Services, Inc.

Key Developments in Global Prefilled Syringes Market

  • In September 2022, Owen Mumford Pharmaceutical Services, a company of Owen Mumford Ltd., received approval for a combination product in Asia for its safety device named 1mL UniSafe for pre-filled syringes. 1mL UniSafe has also received regulatory approval in Europe. The medicine is currently available in the market as a combination product with a rheumatoid arthritis drug.
  • In October 2021, West Pharmaceutical Services, a global leader in innovative solutions for injectable drugs and healthcare products, announced its latest offering for the domestic market in India with the launch of NovaGuard SA Pro Safety System, a single-use accessory for prefilled ISO standard 0.5mL staked needle syringes
  • In October 2020, SCHOTT AG and Credence MedSystems teamed up to use Credence Companion technology in conjunction with TOPPAC, which is a polymer syringe, and syriQ, which is a pre-fillable glass system. The two companies are likely to collaborate to integrate technologies and provide the pharmaceutical industry with a unique and new solution for injectable medicine administration using prefilled syringes.

Each of these players has been profiled in the prefilled syringes market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Global Prefilled Syringes Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 13.6 Bn

Market Forecast Value in 2031

More than US$ 35.7 Bn

Growth Rate (CAGR)

10.1%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • Safety Syringes
    • Conventional Syringes
  • Design
    • Single Chamber
    • Dual Chamber
    • Multiple Chamber
  • Material
    • Glass
    • Plastic
  • Application
    • Chronic Disease Treatment Syringes
    • Vaccine Syringes
    • Anticoagulant Syringes
    • Acute Care and Specialty Syringes
    • Others
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
    • E-commerce

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Rest of APAC
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of MEA

Companies Profiled

  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company (BD)
  • Catalent, Inc.
  • Elcam Medical
  • Gerresheimer AG
  • Nipro Corporation
  • SCHOTT AG
  • Terumo Corporation
  • Vetter Pharma
  • Weigao Group
  • West Pharmaceutical Services, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global prefilled syringes market in 2021?

The global prefilled syringes market was valued at US$ 13.6 Bn in 2021.

How big will be the global prefilled syringes market in 2031?

The global prefilled syringes market is projected to exceed US$ 35.7 Bn by 2031.

What will be the CAGR of the global prefilled syringes market during the forecast period (2022–2031)?

The global prefilled syringes market is anticipated to grow at a CAGR of 10.1% from 2022 to 2031.

Which are the prominent trends that affect market growth?

New product launches and rise in awareness about the benefits of prefilled syringes are the prominent trends in the global market.

What is the market share of the leading segment of the global prefilled syringes market?

The chronic disease treatment segment held over 59% share of the global prefilled syringes market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global prefilled syringes market during the forecast period.

Who are the prominent players in the global prefilled syringes market?

B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company (BD), Catalent, Inc., Elcam Medical, Gerresheimer AG, Nipro Corporation, SCHOTT AG, Terumo Corporation, Vetter Pharma, Weigao Group, and West Pharmaceutical Services, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Venous Diseases Treatment Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Regulatory Scenario by Region/globally

        5.2. Technological Advancements

        5.3. Pipeline Analysis

        5.4. Key Mergers & Acquisitions 

        5.5. Disease Prevalence & Incidence Rate globally with key countries

        5.6. Reimbursement Scenario by Region/globally

    6. Global Prefilled Syringes Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Type, 2017‒2031

            6.3.1. Safety Syringes

            6.3.2. Conventional Syringes

        6.4. Market Attractiveness by Type 

    7. Global Prefilled Syringes Market Analysis and Forecast, by Design

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Design, 2017‒2031

            7.3.1. Single Chambers

            7.3.2. Dual Chamber

            7.3.3. Multiple Chamber

        7.4. Market Attractiveness by Design 

    8. Global Prefilled Syringes Market Analysis and Forecast, by Material

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Material, 2017‒2031

            8.3.1. Glass

            8.3.2. Plastic

        8.4. Market Attractiveness by Material

    9. Global Prefilled Syringes Market Analysis and Forecast, by Application

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Application, 2017‒2031

            9.3.1. Chronic Disease Treatment Syringes

            9.3.2. Vaccine Syringes

            9.3.3. Anticoagulant Syringes

            9.3.4. Acute Care and Specialty Syringes

            9.3.5. Others

        9.4. Market Attractiveness by Application 

    10. Global Prefilled Syringes Market Analysis and Forecast, by Distribution Channel

        10.1. Introduction & Definition

        10.2. Key Findings / Developments

        10.3. Market Value Forecast, by Distribution Channel, 2017‒2031

            10.3.1. Hospital Pharmacies

            10.3.2. Retail Pharmacies & Drug Stores

            10.3.3. E-commerce

        10.4. Market Attractiveness by Distribution Channel

            10.2. Key Findings / Developments

            10.3. Market Value Forecast, by Distribution Channel, 2017‒2031

            10.3.1. Hospital Pharmacies

            10.3.2. Retail Pharmacies & Drug Stores

            10.3.3. E-commerce

        10.5. Market Attractiveness by Distribution Channel

    11. Global Prefilled Syringes Market Analysis and Forecast, by Region

        11.1. Key Findings

        11.2. Market Value Forecast, by Region

            11.2.1. North America

            11.2.2. Europe

            11.2.3. Asia Pacific

            11.2.4. Latin America

            11.2.5. Middle East & Africa

        11.3. Market Attractiveness by Country/Sub-region

    12. North America Prefilled Syringes Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017‒2031

            12.2.1. Safety Syringes

            12.2.2. Conventional Syringes

        12.3. Market Value Forecast, by Design, 2017‒2031

            12.3.1. Single Chambers

            12.3.2. Dual Chamber

            12.3.3. Multiple Chamber

        12.4. Market Value Forecast, by Material, 2017‒2031

            12.4.1. Glass

            12.4.2. Plastic

        12.5. Market Value Forecast, by Application, 2017‒2031

            12.5.1. Chronic Disease Treatment Syringes

            12.5.2. Vaccine Syringes

            12.5.3. Anticoagulant Syringes

            12.5.4. Acute Care and Specialty Syringes

            12.5.5. Others

        12.6. Market Value Forecast, by Distribution Channel, 2017‒2031

            12.6.1. Hospital Pharmacies

            12.6.2. Retail Pharmacies & Drug Stores

            12.6.3. E-commerce

        12.7. Market Value Forecast, by Country, 2017‒2031

            12.7.1. U.S.

            12.7.2. Canada

        12.8. Market Attractiveness Analysis

            12.8.1. By Type

            12.8.2. By Design

            12.8.3. By Material

            12.8.4. By Application

            12.8.5. By Distribution Channel

            12.8.6. By Country

    13. Europe Prefilled Syringes Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017‒2031

            13.2.1. Safety Syringes

            13.2.2. Conventional Syringes

        13.3. Market Value Forecast, by Design, 2017‒2031

            13.3.1. Single Chambers

            13.3.2. Dual Chamber

            13.3.3. Multiple Chamber

        13.4. Market Value Forecast, by Material, 2017‒2031

            13.4.1. Glass

            13.4.2. Plastic

        13.5. Market Value Forecast, by Application, 2017‒2031

            13.5.1. Chronic Disease Treatment Syringes

            13.5.2. Vaccine Syringes

            13.5.3. Anticoagulant Syringes

            13.5.4. Acute Care and Specialty Syringes

            13.5.5. Others

        13.6. Market Value Forecast, by Distribution Channel, 2017‒2031

            13.6.1. Hospital Pharmacies

            13.6.2. Retail Pharmacies & Drug Stores

            13.6.3. E-commerce

        13.7. Market Value Forecast, by Country/Sub-region, 2017‒2031

            13.7.1. Germany

            13.7.2. U.K.

            13.7.3. France

            13.7.4. Italy

            13.7.5. Spain

            13.7.6. Rest of Europe

        13.8. Market Attractiveness Analysis

            13.8.1. By Type

            13.8.2. By Design

            13.8.3. By Material

            13.8.4. By Application

            13.8.5. By Distribution Channel

            13.8.6. By Country/Sub-region

    14. Asia Pacific Prefilled Syringes Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Type, 2017‒2031

            14.2.1. Safety Syringes

            14.2.2. Conventional Syringes

        14.3. Market Value Forecast, by Design, 2017‒2031

            14.3.1. Single Chambers

            14.3.2. Dual Chamber

            14.3.3. Multiple Chamber

        14.4. Market Value Forecast, by Material, 2017‒2031

            14.4.1. Glass

            14.4.2. Plastic

        14.5. Market Value Forecast, by Application, 2017‒2031

            14.5.1. Chronic Disease Treatment Syringes

            14.5.2. Vaccine Syringes

            14.5.3. Anticoagulant Syringes

            14.5.4. Acute Care and Specialty Syringes

            14.5.5. Others

        14.6. Market Value Forecast, by Distribution Channel, 2017‒2031

            14.6.1. Hospital Pharmacies

            14.6.2. Retail Pharmacies & Drug Stores

            14.6.3. E-commerce

        14.7. Market Value Forecast, by Country/Sub-region, 2017‒2031

            14.7.1. Japan

            14.7.2. China

            14.7.3. India

            14.7.4. Australia & New Zealand

            14.7.5. Rest of Asia Pacific

        14.8. Market Attractiveness Analysis

            14.8.1. By Type

            14.8.2. By Design

            14.8.3. By Material

            14.8.4. By Application

            14.8.5. By Distribution Channel

            14.8.6. By Country/Sub-region

    15. Latin America Prefilled Syringes Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Type, 2017‒2031

            15.2.1. Safety Syringes

            15.2.2. Conventional Syringes

        15.3. Market Value Forecast, by Design, 2017‒2031

            15.3.1. Single Chambers

            15.3.2. Dual Chamber

            15.3.3. Multiple Chamber

        15.4. Market Value Forecast, by Material, 2017‒2031

            15.4.1. Glass

            15.4.2. Plastic

        15.5. Market Value Forecast, by Application, 2017‒2031

            15.5.1. Chronic Disease Treatment Syringes

            15.5.2. Vaccine Syringes

            15.5.3. Anticoagulant Syringes

            15.5.4. Acute Care and Specialty Syringes

            15.5.5. Others

        15.6. Market Value Forecast, by Distribution Channel, 2017‒2031

            15.6.1. Hospital Pharmacies

            15.6.2. Retail Pharmacies & Drug Stores

            15.6.3. E-commerce

        15.7. Market Value Forecast, by Country/Sub-region, 2017‒2031

            15.7.1. Brazil

            15.7.2. Mexico

            15.7.3. Rest of Latin America

        15.8. Market Attractiveness Analysis

            15.8.1. By Type

            15.8.2. By Design

            15.8.3. By Material

            15.8.4. By Application

            15.8.5. By Distribution Channel

            15.8.6. By Country/Sub-region

    16. Middle East & Africa Prefilled Syringes Market Analysis and Forecast

        16.1. Introduction

            16.1.1. Key Findings

        16.2. Market Value Forecast, by Type, 2017‒2031

            16.2.1. Safety Syringes

            16.2.2. Conventional Syringes

        16.3. Market Value Forecast, by Design, 2017‒2031

            16.3.1. Single Chambers

            16.3.2. Dual Chamber

            16.3.3. Multiple Chamber

        16.4. Market Value Forecast, by Material, 2017‒2031

            16.4.1. Glass

            16.4.2. Plastic

        16.5. Market Value Forecast, by Application, 2017‒2031

            16.5.1. Chronic Disease Treatment Syringes

            16.5.2. Vaccine Syringes

            16.5.3. Anticoagulant Syringes

            16.5.4. Acute Care and Specialty Syringes

            16.5.5. Others

        16.6. Market Value Forecast, by Distribution Channel, 2017‒2031

            16.6.1. Hospital Pharmacies

            16.6.2. Retail Pharmacies & Drug Stores

            16.6.3. E-commerce

        16.7. Market Value Forecast, by Country/Sub-region, 2017‒2031

            16.7.1. GCC Countries

            16.7.2. South Africa

            16.7.3. Rest of Middle East & Africa

        16.8. Market Attractiveness Analysis

            16.8.1. By Type

            16.8.2. By Design

            16.8.3. By Material

            16.8.4. By Application

            16.8.5. By Distribution Channel

            16.8.6. By Country/Sub-region

    17. Competitive Landscape

        17.1. Market Player - Competition Matrix (by tier and size of companies)

        17.2. Market Share Analysis, by Company, 2021

        17.3. Company Profiles

            17.3.1. Zimmer Biomet Holdings, Inc.

                17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.1.2. Company Financials

                17.3.1.3. Growth Strategies

                17.3.1.4. SWOT Analysis

            17.3.2. Medtronic

                17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.2.2. Company Financials

                17.3.2.3. Growth Strategies

                17.3.2.4. SWOT Analysis

            17.3.3. AngioDynamics

                17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.3.2. Company Financials

                17.3.3.3. Growth Strategies

                17.3.3.4. SWOT Analysis

            17.3.4. Alma Lasers

                17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.4.2. Company Financials

                17.3.4.3. Growth Strategies

                17.3.4.4. SWOT Analysis

            17.3.5. Biolitec AG Untere Viaduktgasse

                17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.5.2. Company Financials

                17.3.5.3. Growth Strategies

                17.3.5.4. SWOT Analysis

            17.3.6. Becton, Dickinson and Company

                17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.6.2. Company Financials

                17.3.6.3. Growth Strategies

                17.3.6.4. SWOT Analysis

            17.3.7. Boston Scientific Corporation

                17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.7.2. Company Financials

                17.3.7.3. Growth Strategies

                17.3.7.4. SWOT Analysis

            17.3.8. Abbott Laboratories

                17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.8.2. Company Financials

                17.3.8.3. Growth Strategies

                17.3.8.4. SWOT Analysis

            17.3.9. B. Braun Melsungen AG

                17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.9.2. Company Financials

                17.3.9.3. Growth Strategies

                17.3.9.4. SWOT Analysis

            17.3.10. Teleflex Incorporated

                17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.10.2. Company Financials

                17.3.10.3. Growth Strategies

                17.3.10.4. SWOT Analysis

            17.3.11. Lumenis

                17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.11.2. Company Financials

                17.3.11.3. Growth Strategies

                17.3.11.4. SWOT Analysis

            17.3.12. Philips

                17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.12.2. Company Financials

                17.3.12.3. Growth Strategies

                17.3.12.4. SWOT Analysis

    List of Tables

    Table 01: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 02: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 03: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 04: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 05: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 06: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Region, 2017–2031

    Table 07: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 08: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 09: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 10: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 11: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 12: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Country, 2017–2031

    Table 13: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 14: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 15: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 16: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 17: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 18: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 19: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 20: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 21: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 22: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 23: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 24: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 25: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 26: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 27: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 28: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 29: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 30: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 31: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017–2031

    Table 32: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017–2031

    Table 33: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017–2031

    Table 34: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017–2031

    Table 35: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

    Table 36: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 02: Global Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 03: Global Prefilled Syringes Market Attractiveness Index Analysis, by Type, 2022–2031

    Figure 04: Global Prefilled Syringes Market Revenue (US$ Bn), by Safety Syringes, 2017–2031

    Figure 05: Global Prefilled Syringes Market Revenue (US$ Bn), by Conventional Syringes, 2017–2031

    Figure 06: Global Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 07: Global Prefilled Syringes Market Attractiveness Index Analysis, by Design, 2022–2031

    Figure 08: Global Prefilled Syringes Market Revenue (US$ Bn), by Single Chambers, 2017–2031

    Figure 09: Global Prefilled Syringes Market Revenue (US$ Bn), by Industry, 2017–2031

    Figure 10: Global Prefilled Syringes Market Revenue (US$ Bn), by Multiple Chamber, 2017–2031

    Figure 11: Global Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 12: Global Prefilled Syringes Market Attractiveness Index Analysis, by Material, 2022–2031

    Figure 13: Global Prefilled Syringes Market Revenue (US$ Bn), by Plastic, 2017–2031

    Figure 14: Global Prefilled Syringes Market Revenue (US$ Bn), by Glass, 2017–2031

    Figure 15: Global Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 16: Global Prefilled Syringes Market Attractiveness Index Analysis, by Application, 2022–2031

    Figure 17: Global Prefilled Syringes Market Revenue (US$ Bn), by Chronic Disease Treatment Syringes, 2017–2031

    Figure 18: Global Prefilled Syringes Market Revenue (US$ Bn), by Vaccine Syringes, 2017–2031

    Figure 19: Global Prefilled Syringes Market Revenue (US$ Bn), by Anticoagulant Syringes, 2017–2031

    Figure 20: Global Prefilled Syringes Market Revenue (US$ Bn), by Acute Care & Specialty Syringes, 2017–2031

    Figure 21: Global Prefilled Syringes Market Revenue (US$ Bn), by Others, 2017–2031

    Figure 22: Global Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 23: Global Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 24: Global Prefilled Syringes Market Value (US$ Bn), by Hospital Pharmacies, 2017–2031

    Figure 25: Global Prefilled Syringes Market Value (US$ Bn), by Retail Pharmacies & Drug Stores, 2017–2031

    Figure 26: Global Prefilled Syringes Market Value (US$ Bn), by E-commerce, 2017–2031

    Figure 27: Global Prefilled Syringes Market Value Share Analysis, by Region, 2021 and 2031

    Figure 28: Global Prefilled Syringes Market Attractiveness Analysis, by Region, 2021–2031

    Figure 29: North America Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 30: North America Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 31: North America Prefilled Syringes Market Attractiveness index Analysis, by Type, 2022–2031

    Figure 32: North America Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 33: North America Prefilled Syringes Market Attractiveness index Analysis, by Design, 2022–2031

    Figure 34: North America Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 35: North America Prefilled Syringes Market Attractiveness index Analysis, by Material, 2022–2031

    Figure 36: North America Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 37: North America Prefilled Syringes Market Attractiveness index Analysis, by Application, 2022–2031

    Figure 38: North America Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 39: North America Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 40: North America Prefilled Syringes Market Value Share Analysis, by Country, 2021 and 2031

    Figure 41: North America Prefilled Syringes Market Attractiveness Analysis, by Country, 2022–2031

    Figure 42: Europe Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 43: Europe Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 44: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Type, 2022–2031

    Figure 45: Europe Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 46: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Design, 2022–2031

    Figure 47: Europe Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 48: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Material, 2022–2031

    Figure 49: Europe Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 50: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Application, 2022–2031

    Figure 51: Europe Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 52: Europe Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 53: Europe Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 54: Europe Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 55: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 56: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 57: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Type, 2022–2031

    Figure 58: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 59: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Design, 2022–2031

    Figure 60: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 61: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Material, 2022–2031

    Figure 62: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 63: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Application, 2022–2031

    Figure 64: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 65: Asia Pacific Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 66: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 67: Asia Pacific Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 68: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 69: Latin America Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 70: Latin America Prefilled Syringes Market Attractiveness Analysis, by Type, 2022–2031

    Figure 71: Latin America Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 72: Latin America Prefilled Syringes Market Attractiveness Analysis, by Design, 2022–2031

    Figure 73: Latin America Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 74: Latin America Prefilled Syringes Market Attractiveness Analysis, by Material, 2022–2031

    Figure 75: Latin America Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 76: Latin America Prefilled Syringes Market Attractiveness Analysis, by Application, 2022–2031

    Figure 77: Latin America Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 78: Latin America Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 79: Latin America Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 80: Latin America Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 81: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 82: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031

    Figure 83: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Type, 2022–2031

    Figure 84: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031

    Figure 85: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Design, 2022–2031

    Figure 86: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031

    Figure 87: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Material, 2022–2031

    Figure 88: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031

    Figure 89: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Application, 2022–2031

    Figure 90: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 91: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 92: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 93: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved